Tetherex Pharmaceuticals Corp's Series B Round

Tetherex Pharmaceuticals Corp raised a round of funding on March 06, 2018.

Tetherex Pharmaceuticals Corp is a clinical-stage development biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across…

Articles about Tetherex Pharmaceuticals Corp's Series B Round: